APO RESEARCH · REPORT
Drug Delivery Devices
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
Product & engineering
Understand the product.
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
Selected research
Industry Research
Drug Delivery Devices Industry Research Report 2026
Market perspective
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world's research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
Report Scope
Read the full market overview
This report quantifies the global Drug Delivery Devices market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Delivery Devices.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Delivery Devices Market by Company
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
Drug Delivery Devices Segment by Type
Injection Type
Mucosal Type
Implanted Type
Others Type
Drug Delivery Devices Segment by Application
Pharmaceutical Companies
Hospitals
Clinics
Other
Drug Delivery Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Delivery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Delivery Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection Type
- Mucosal Type
- Implanted Type
- Others Type
Applications
- Pharmaceutical Companies
- Hospitals
- Clinics
- Other
Companies covered
- Cipla
- Baxter International
- Nipro Corporation
- Roche
- Boehringer Ingelheim
- Allergan
- 3M
- BD
- Catalent
- Valeant Pharmaceuticals
- Bayer AG
- Chiesi
- Phillips-Medisize
- Johnson & Johnson
- Shandong Weigao
- Pfizer
- B.Braun
- Novartis AG
- Zhengkang
- Gerresheimer
- COVIDIEN Medtronic
- Schott forma vitrum
- Alkermes
- Skyepharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Delivery Devices by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Injection Type
- 2.2.3 Mucosal Type
- 2.2.4 Implanted Type
- 2.2.5 Others Type
- 2.3 Drug Delivery Devices by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Hospitals
- 2.3.4 Clinics
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Drug Delivery Devices Breakdown Data by Type
- 3.1 Global Drug Delivery Devices Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Delivery Devices Forecasted Market Size by Type (2027-2032)
4 Drug Delivery Devices Breakdown Data by Application
- 4.1 Global Drug Delivery Devices Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Delivery Devices Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Delivery Devices Market Perspective (2021-2032)
- 5.2 Global Drug Delivery Devices Growth Trends by Region
- 5.2.1 Global Drug Delivery Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Delivery Devices Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Delivery Devices Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Delivery Devices Market Dynamics
- 5.3.1 Drug Delivery Devices Industry Trends
- 5.3.2 Drug Delivery Devices Market Drivers
- 5.3.3 Drug Delivery Devices Market Challenges
- 5.3.4 Drug Delivery Devices Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Delivery Devices Players by Revenue
- 6.1.1 Global Top Drug Delivery Devices Players by Revenue (2021-2026)
- 6.1.2 Global Drug Delivery Devices Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Delivery Devices Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Delivery Devices Head Office and Area Served
- 6.4 Global Drug Delivery Devices Players, Product Type & Application
- 6.5 Global Drug Delivery Devices Manufacturers Established Date
- 6.6 Global Drug Delivery Devices Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Delivery Devices Market Size (2021-2032)
- 7.2 North America Drug Delivery Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Delivery Devices Market Size by Country (2021-2026)
- 7.4 North America Drug Delivery Devices Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Delivery Devices Market Size (2021-2032)
- 8.2 Europe Drug Delivery Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Delivery Devices Market Size by Country (2021-2026)
- 8.4 Europe Drug Delivery Devices Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Delivery Devices Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Delivery Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Delivery Devices Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Delivery Devices Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Delivery Devices Market Size (2021-2032)
- 10.2 South America Drug Delivery Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Delivery Devices Market Size by Country (2021-2026)
- 10.4 South America Drug Delivery Devices Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Delivery Devices Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Delivery Devices Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Delivery Devices Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Delivery Devices Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Cipla
- 12.1.1 Cipla Company Information
- 12.1.2 Cipla Business Overview
- 12.1.3 Cipla Revenue in Drug Delivery Devices Business (2021-2026)
- 12.1.4 Cipla Drug Delivery Devices Product Portfolio
- 12.1.5 Cipla Recent Developments
- 12.2 Baxter International
- 12.2.1 Baxter International Company Information
- 12.2.2 Baxter International Business Overview
- 12.2.3 Baxter International Revenue in Drug Delivery Devices Business (2021-2026)
- 12.2.4 Baxter International Drug Delivery Devices Product Portfolio
- 12.2.5 Baxter International Recent Developments
- 12.3 Nipro Corporation
- 12.3.1 Nipro Corporation Company Information
- 12.3.2 Nipro Corporation Business Overview
- 12.3.3 Nipro Corporation Revenue in Drug Delivery Devices Business (2021-2026)
- 12.3.4 Nipro Corporation Drug Delivery Devices Product Portfolio
- 12.3.5 Nipro Corporation Recent Developments
- 12.4 Roche
- 12.4.1 Roche Company Information
- 12.4.2 Roche Business Overview
- 12.4.3 Roche Revenue in Drug Delivery Devices Business (2021-2026)
- 12.4.4 Roche Drug Delivery Devices Product Portfolio
- 12.4.5 Roche Recent Developments
- 12.5 Boehringer Ingelheim
- 12.5.1 Boehringer Ingelheim Company Information
- 12.5.2 Boehringer Ingelheim Business Overview
- 12.5.3 Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2021-2026)
- 12.5.4 Boehringer Ingelheim Drug Delivery Devices Product Portfolio
- 12.5.5 Boehringer Ingelheim Recent Developments
- 12.6 Allergan
- 12.6.1 Allergan Company Information
- 12.6.2 Allergan Business Overview
- 12.6.3 Allergan Revenue in Drug Delivery Devices Business (2021-2026)
- 12.6.4 Allergan Drug Delivery Devices Product Portfolio
- 12.6.5 Allergan Recent Developments
- 12.7 3M
- 12.7.1 3M Company Information
- 12.7.2 3M Business Overview
- 12.7.3 3M Revenue in Drug Delivery Devices Business (2021-2026)
- 12.7.4 3M Drug Delivery Devices Product Portfolio
- 12.7.5 3M Recent Developments
- 12.8 BD
- 12.8.1 BD Company Information
- 12.8.2 BD Business Overview
- 12.8.3 BD Revenue in Drug Delivery Devices Business (2021-2026)
- 12.8.4 BD Drug Delivery Devices Product Portfolio
- 12.8.5 BD Recent Developments
- 12.9 Catalent
- 12.9.1 Catalent Company Information
- 12.9.2 Catalent Business Overview
- 12.9.3 Catalent Revenue in Drug Delivery Devices Business (2021-2026)
- 12.9.4 Catalent Drug Delivery Devices Product Portfolio
- 12.9.5 Catalent Recent Developments
- 12.10 Valeant Pharmaceuticals
- 12.10.1 Valeant Pharmaceuticals Company Information
- 12.10.2 Valeant Pharmaceuticals Business Overview
- 12.10.3 Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2021-2026)
- 12.10.4 Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
- 12.10.5 Valeant Pharmaceuticals Recent Developments
- 12.11 Bayer AG
- 12.11.1 Bayer AG Company Information
- 12.11.2 Bayer AG Business Overview
- 12.11.3 Bayer AG Revenue in Drug Delivery Devices Business (2021-2026)
- 12.11.4 Bayer AG Drug Delivery Devices Product Portfolio
- 12.11.5 Bayer AG Recent Developments
- 12.12 Chiesi
- 12.12.1 Chiesi Company Information
- 12.12.2 Chiesi Business Overview
- 12.12.3 Chiesi Revenue in Drug Delivery Devices Business (2021-2026)
- 12.12.4 Chiesi Drug Delivery Devices Product Portfolio
- 12.12.5 Chiesi Recent Developments
- 12.13 Phillips-Medisize
- 12.13.1 Phillips-Medisize Company Information
- 12.13.2 Phillips-Medisize Business Overview
- 12.13.3 Phillips-Medisize Revenue in Drug Delivery Devices Business (2021-2026)
- 12.13.4 Phillips-Medisize Drug Delivery Devices Product Portfolio
- 12.13.5 Phillips-Medisize Recent Developments
- 12.14 Johnson & Johnson
- 12.14.1 Johnson & Johnson Company Information
- 12.14.2 Johnson & Johnson Business Overview
- 12.14.3 Johnson & Johnson Revenue in Drug Delivery Devices Business (2021-2026)
- 12.14.4 Johnson & Johnson Drug Delivery Devices Product Portfolio
- 12.14.5 Johnson & Johnson Recent Developments
- 12.15 Shandong Weigao
- 12.15.1 Shandong Weigao Company Information
- 12.15.2 Shandong Weigao Business Overview
- 12.15.3 Shandong Weigao Revenue in Drug Delivery Devices Business (2021-2026)
- 12.15.4 Shandong Weigao Drug Delivery Devices Product Portfolio
- 12.15.5 Shandong Weigao Recent Developments
- 12.16 Pfizer
- 12.16.1 Pfizer Company Information
- 12.16.2 Pfizer Business Overview
- 12.16.3 Pfizer Revenue in Drug Delivery Devices Business (2021-2026)
- 12.16.4 Pfizer Drug Delivery Devices Product Portfolio
- 12.16.5 Pfizer Recent Developments
- 12.17 B.Braun
- 12.17.1 B.Braun Company Information
- 12.17.2 B.Braun Business Overview
- 12.17.3 B.Braun Revenue in Drug Delivery Devices Business (2021-2026)
- 12.17.4 B.Braun Drug Delivery Devices Product Portfolio
- 12.17.5 B.Braun Recent Developments
- 12.18 Novartis AG
- 12.18.1 Novartis AG Company Information
- 12.18.2 Novartis AG Business Overview
- 12.18.3 Novartis AG Revenue in Drug Delivery Devices Business (2021-2026)
- 12.18.4 Novartis AG Drug Delivery Devices Product Portfolio
- 12.18.5 Novartis AG Recent Developments
- 12.19 Zhengkang
- 12.19.1 Zhengkang Company Information
- 12.19.2 Zhengkang Business Overview
- 12.19.3 Zhengkang Revenue in Drug Delivery Devices Business (2021-2026)
- 12.19.4 Zhengkang Drug Delivery Devices Product Portfolio
- 12.19.5 Zhengkang Recent Developments
- 12.20 Gerresheimer
- 12.20.1 Gerresheimer Company Information
- 12.20.2 Gerresheimer Business Overview
- 12.20.3 Gerresheimer Revenue in Drug Delivery Devices Business (2021-2026)
- 12.20.4 Gerresheimer Drug Delivery Devices Product Portfolio
- 12.20.5 Gerresheimer Recent Developments
- 12.21 COVIDIEN Medtronic
- 12.21.1 COVIDIEN Medtronic Company Information
- 12.21.2 COVIDIEN Medtronic Business Overview
- 12.21.3 COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2021-2026)
- 12.21.4 COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
- 12.21.5 COVIDIEN Medtronic Recent Developments
- 12.22 Schott forma vitrum
- 12.22.1 Schott forma vitrum Company Information
- 12.22.2 Schott forma vitrum Business Overview
- 12.22.3 Schott forma vitrum Revenue in Drug Delivery Devices Business (2021-2026)
- 12.22.4 Schott forma vitrum Drug Delivery Devices Product Portfolio
- 12.22.5 Schott forma vitrum Recent Developments
- 12.23 Alkermes
- 12.23.1 Alkermes Company Information
- 12.23.2 Alkermes Business Overview
- 12.23.3 Alkermes Revenue in Drug Delivery Devices Business (2021-2026)
- 12.23.4 Alkermes Drug Delivery Devices Product Portfolio
- 12.23.5 Alkermes Recent Developments
- 12.24 Skyepharma
- 12.24.1 Skyepharma Company Information
- 12.24.2 Skyepharma Business Overview
- 12.24.3 Skyepharma Revenue in Drug Delivery Devices Business (2021-2026)
- 12.24.4 Skyepharma Drug Delivery Devices Product Portfolio
- 12.24.5 Skyepharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst